Posts Categorized: Bristol Myers Squibb

Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism

Pfizer and Bristol-Myers Squibb (BMS) are collaborating to provide grant support for continuing professional education in the areas of atrial fibrillation and venous thromboembolism. We are committed to supporting innovative, independent medical education for healthcare professionals. Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to… Read more »

Bristol-Myers Squibb/Pfizer Alliance – Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism RFP

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding… Read more »

Bristol Myers Squibb | Pfizer – Atrial Fibrillation and Venous Thromboembolism – Request for Proposals

Pfizer and Bristol-Myers Squibb (BMS) are collaborating to provide grant support for continuing professional education in the areas of atrial fibrillation and venous thromboembolism. We are committed to supporting innovative, independent medical education for healthcare professionals. Grants via this collaboration will be funded by Pfizer, but reviewed and approved by both companies. Pfizer Global Medical… Read more »